See also this year's filing and all EDGAR filings for this company.
PDF Report 0001094038_2023_Marker_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001094038, Marker Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 16,619,255 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 17,802,929 |
| 4 | LiabilitiesCurrent | 7,781,809 |
| 5 | LiabilitiesNoncurrent | 7,039,338 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,820,004 |
| 9 | ResearchAndDevelopmentExpense | 26,139,323 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 9,013,544 |
| 12 | remainder_NetIncome | 15,089 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 34,422,184 |
| 1 | Liabilities | 14,821,147 |
| 2 | Expenses | 38,959,327 |
| 3 | Revenues | 9,013,544 |
| 4 | StockholdersEquity | 19,601,037 |
| 5 | NetIncome | -29,930,694 |
| 6 | ComprehensiveNetIncome | -29,930,694 |
| 7 | BaseVar | 48,615,646 |
| 8 | EconomicCapitalRatio | 0.154 |